SciClone Pharmaceuticals (SCLN +5.8%) gets a big boost today from an upgrade to Buy from Hold at...


SciClone Pharmaceuticals (SCLN +5.8%) gets a big boost today from an upgrade to Buy from Hold at Aegis Capital. The firm also set a $9 price target. The stock has had a solid run recently, gaining 12% over the past week.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs